DEC 09, 2019 4:14 PM PST

Astronauts help to advanced personalized medicine

WRITTEN BY: Tara Fernandez

Extreme temperatures and lethal levels of radiation are just some of the hazards faced by astronauts as they traverse the harsh conditions of space.

Additionally, space travelers on extended journeys are also subject to an accelerated aging phenomenon -- with effects like bone density loss, the hardening of blood vessels, and diminishing muscle mass.

Space health researchers like Dr. Annette Sobel, professor at the Texas Tech University of Health Sciences Center, are taking advantage of cutting edge diagnostic technologies to better understand and manage the physically demanding aspects of interplanetary voyages.

Dr. Sobel is part of a team developing personalized medical support to astronauts, and in doing so, propelling the possibility of early disease detection and precision care for patients on Earth.

For astronauts on long space missions, dropping into a clinic upon the first signs of a medical condition is not an option. In light of this, the astronauts’ health needs to be vigilantly monitored before take-off. Using genomic analysis techniques, space health teams are able to predict the risk of a particular disease developing in an individual and customize a preventative intervention plan accordingly. 

Dr. Sobel uses a variety of genomics, proteomics and metabolomics tools which allow her team to simulate disease progression based on a person’s genetic profile. Our genetic code holds a wealth of information: the number and combinations of genes speak to the chances of developing certain diseases, as well as the potential for experiencing side effects to drugs.

Here on earth, lessons learned from these innovations are already being translated to a better standard of care for many common illnesses. For instance, glaucoma is a leading cause of blindness in people over 60, caused by abnormally high pressure in the eyeball. Now, an increased understanding of the genetics of glaucoma progression, using the same techniques used to study astronauts, can empower clinicians and patients with more predictive power to halt disease progression earlier.

The next frontier for personalized medicine could mean that, like astronauts headed for galaxy explorations, we no longer have to wait for symptoms to develop before receiving clinical care.

Source: Mobi Health News

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 17, 2020
Clinical & Molecular DX
Smartphone Cameras Detect Signs of Diabetes
AUG 17, 2020
Smartphone Cameras Detect Signs of Diabetes
In the future, detecting the early signs of diabetes could be as simple as picking up your smartphone. A new study, rece ...
AUG 24, 2020
Clinical & Molecular DX
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
AUG 24, 2020
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
Magnetic resonance imaging, or MRI, is a medical imaging technique that uses powerful magnetic fields and radio waves to ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
OCT 01, 2020
Clinical & Molecular DX
Presenting the World's Smallest Ultrasound Detector
OCT 01, 2020
Presenting the World's Smallest Ultrasound Detector
It’s smaller than a human cell, but the diminutive size of the newly-developed ultrasound detector is by no means ...
OCT 27, 2020
Clinical & Molecular DX
A Super Sensitive Alzheimer's Test Powered by Nanozymes
OCT 27, 2020
A Super Sensitive Alzheimer's Test Powered by Nanozymes
  Simple tasks are now uphill struggles, social situations aren’t fun, and the car keys are missing again. By ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
Loading Comments...